Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES2 | Q9H7Z7 | 9/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | HTT | P42858 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Artemisin SCHEMBL19600819 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 | |
| Artemisinin SCHEMBL60304 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 | |
| Artemisin SCHEMBL11959711 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 | |
| Artemisin SCHEMBL7071338 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 | |
| Artemisin SCHEMBL23843508 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 | |
| Artemisin SCHEMBL13428542 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 | |
| Artemisin SCHEMBL23974927 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 | |
| Artemisin SCHEMBL16587860 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 | |
| Artemisin SCHEMBL16587369 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 | |
| Artemisin SCHEMBL9884398 | 1.00 | PTGES2 (1.00) | PTGES2ALDH1A1LMNAHTTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9802952-B2 | Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives | Max-Plank-Gesellschaft zur Förderung der Wissenschaften e.v. (DE) | 2017-10-31 | — | — | US | disclosed |
| EP-3022208-B1 | METHOD AND APPARATUS FOR THE SYNTHESIS OF DIHYDROARTEMISININ AND ARTEMISININ DERIVATIVES | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS (DE) | 2017-06-14 | — | — | EP | disclosed |
| US-8129426-B2 | Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2012-03-06 | — | — | US | disclosed |
| US-7910750-B2 | Aryl ethers of dihydroartemisnin such as 4-methoxycarbonylmethyl phenyl-dihydroartemisinine ether; immunosuppressants; dosage forms including tablets, ointments and suppositories; side effect reduction over cyclosporin A | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2011-03-22 | — | — | US | disclosed |
| US-20080139642-A1 | Artemisinin (Qinghaosu) Derivatives, Their Preparation Methods And Their Use, And Pharmaceutical Compositions Containing The Same | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139642-A1 | Artemisinin (Qinghaosu) Derivatives, Their Preparation Methods And Their Use, And Pharmaceutical Compositions Containing The Same | THPO, CYP3A5, CYP3A43 | PTGES2 77/4885ALDH1A1 951/4885LMNA 3249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.